Sign In
Buy SGHT
$7.03
-0.0800 (-1.13%)
At Close: Nov 17, 2025
Sight Sciences (SGHT) Upgraded to Buy: Here's What You Should Know
01:01pm, Tuesday, 11'th Nov 2025
Sight Sciences (SGHT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript
10:16pm, Thursday, 06'th Nov 2025
Sight Sciences, Inc. ( SGHT ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Paul Badawi - Co-Founder, President, CEO & Director Jim Rodberg - VP of Finance & Corporate Contro
Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:31pm, Thursday, 06'th Nov 2025
The headline numbers for Sight Sciences (SGHT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
07:55pm, Thursday, 06'th Nov 2025
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.22 per share a year ago.
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
04:05pm, Thursday, 06'th Nov 2025
MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
04:04pm, Thursday, 06'th Nov 2025
New leadership appointments strengthen Sight Sciences' commitment to advancing our interventional dry eye initiatives and driving scalable operations and growth New leadership appointments strengthen
Sight Sciences to Present at Two Upcoming Investor Conferences
04:05pm, Tuesday, 04'th Nov 2025
MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 23'rd Oct 2025
MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
MENLO PARK, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
08:35am, Friday, 19'th Sep 2025
Sight Sciences highlights a new meta-analysis showing OMNI delivers lasting safety, efficacy and economic value in glaucoma treatment.
MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing inno
Sight Sciences, Inc. (SGHT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
05:13pm, Wednesday, 10'th Sep 2025
Sight Sciences, Inc. (NASDAQ:SGHT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:50 PM EDT Company Participants Paul Badawi - Co-Founder, President, CEO & Director Alis
UnitedHealthcare's Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessary UnitedHealthcare's Coverage Pol
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
04:05pm, Tuesday, 02'nd Sep 2025
This report provides an evidence-based review of current treatments for managing dry eye disease (DED) and highlights support for TearCare based on strong clinical data This report provides an evidenc
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
04:05pm, Tuesday, 26'th Aug 2025
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innova
